Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$0.17 - $0.26 $706 - $1,080
-4,154 Reduced 4.58%
86,642 $15,000
Q2 2022

Aug 15, 2022

SELL
$0.2 - $0.61 $17,198 - $52,456
-85,994 Reduced 48.64%
90,796 $19,000
Q1 2022

May 16, 2022

SELL
$0.48 - $0.74 $196,476 - $302,901
-409,326 Reduced 69.84%
176,790 $110,000
Q4 2021

Feb 14, 2022

BUY
$0.7 - $1.94 $410,281 - $1.14 Million
586,116 New
586,116 $410,000
Q3 2021

Nov 15, 2021

SELL
$1.82 - $5.71 $24,171 - $75,834
-13,281 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$5.22 - $7.33 $1.11 Million - $1.56 Million
-213,256 Reduced 94.14%
13,281 $77,000
Q1 2021

May 17, 2021

BUY
$4.0 - $10.28 $906,148 - $2.33 Million
226,537 New
226,537 $1.47 Million

Others Institutions Holding HEXO

About HEXO Corp.


  • Ticker HEXO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 601,395,008
  • Description
  • HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up b...
More about HEXO
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.